Literature DB >> 1554743

Saposin-C from bovine spleen; complete amino acid sequence and relation between the structure and its biological activity.

A Sano1, T Mizuno, K Kondoh, T Hineno, S Ueno, Y Kakimoto, N Morita.   

Abstract

Saposin-C, a small acidic glycoprotein that can activate glucosylceramide-beta-glucosidase, has been isolated from bovine spleen. The complete amino acid sequence of bovine saposin-C was determined by Edman degradation of the purified protein and its fragmented peptides. It contains 80 amino acids, one carbohydrate chain attached to a single asparagine residue and six cysteine residues in oxidized form. The sequence of bovine saposin-C is 76 and 65% identical with the sequences of saposin-C from human spleen and guinea pig liver, respectively. Hydropathy profiles of the sequence of saposin-C from three species were similar despite the significant residue substitutions. Bovine saposin-C had a stronger effect in stimulating bovine beta-glucosidase compared to human saposin-C. However, the effect of human saposin-C in stimulating human enzyme was stronger than that of bovine saposin-C. The region around residue 35, which is next to the extremely hydrophilic region, seems to be important to produce an interaction with the enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554743     DOI: 10.1016/0167-4838(92)90426-e

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Cloning, expression and map assignment of chicken prosaposin.

Authors:  N Azuma; H C Seo; O Lie; Q Fu; R M Gould; M Hiraiwa; D W Burt; I R Paton; D R Morrice; J S O'Brien; Y Kishimoto
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

2.  Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.

Authors:  Ana M Espino; Adelaida Morales; Bonnibel Delgado; Francheska M Rivera; Olgary Figueroa; Erick Suárez
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

Review 3.  Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka
Journal:  Anat Sci Int       Date:  2021-02-03       Impact factor: 1.741

4.  Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.

Authors:  Daricel Torres; Ana M Espino
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2.

Authors:  Marcos J Ramos-Benítez; Luis M Lopez-Cruz; Vasti Aguayo; Caleb Ruiz-Jimenez; Ana M Espino
Journal:  Mol Biol Rep       Date:  2018-07-21       Impact factor: 2.316

6.  Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.

Authors:  Ana M Espino; Daricel Torres; Adelaida Morales; Bonnibel Delgado; Julia Quetel; Antonio Osuna
Journal:  Exp Parasitol       Date:  2007-03-27       Impact factor: 2.011

7.  Prosaposin overexpression following kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka; Keigo Uematsu; Hiroko Takechi; Tetsuya Shimokawa; Kimiko Yamamiya; Cheng Li; Takuya Doihara; Shouichiro Saito; Naoto Kobayashi; Seiji Matsuda
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

8.  A prosaposin-derived Peptide alleviates kainic Acid-induced brain injury.

Authors:  Hiroaki Nabeka; Tetsuya Shimokawa; Takuya Doihara; Shouichiro Saito; Hiroyuki Wakisaka; Fumihiko Hamada; Naoto Kobayashi; Seiji Matsuda
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

9.  Interneurons secrete prosaposin, a neurotrophic factor, to attenuate kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka; Shouichiro Saito; Xuan Li; Tetsuya Shimokawa; Md Sakirul Islam Khan; Kimiko Yamamiya; Soichiro Kawabe; Takuya Doihara; Fumihiko Hamada; Naoto Kobayashi; Seiji Matsuda
Journal:  IBRO Rep       Date:  2017-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.